Drug Tariff Pro Ltd vs Faks: Revenue, Funding & Team Size Compared
Drug Tariff Pro Ltd has not disclosed its revenue; Faks generates $8.6M. The table below compares Drug Tariff Pro Ltd and Faks on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  Drug Tariff Pro LtdThis company |  Faks |
|---|---|---|
| Revenue | Not disclosed | $8.6M |
| HQ | United States | United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Drug Tariff Pro Ltd at a glance
Simplify the Drug Tariff: Only essential info, clear definitions. Merges reimbursement, net, and concession prices onto one platform. Track with watchlists! #HealthTech #Pharma
Faks at a glance
Faks generates $8.6M in revenue, headquartered in United States.
- Revenue
- $8.6M
Faks is a technology company based in Paris that specializes in app development aimed at facilitating communication between pharmacies and laboratories. The application helps users send faster requests, track the status of these requests…
Other Drug Tariff Pro Ltd alternatives
Drug Tariff Pro Ltd competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Drug Tariff Pro Ltd vs Faks: frequently asked questions
How much revenue does Faks make?
Faks generates $8.6M in annual revenue.